Results 1 to 5 of 6
Most popular |Most recent

SPACs 101 FAQ: A Primer on Today’s Hottest Exit Strategy

USA - January 15 2021 SPACs, shorthand for special purpose acquisition companies, have become this year’s most popular alternative option for private companies to access…

James D. Evans, Nicolas H.R. Dumont, Scott A. Behar.

Financial Projections in SPAC Transactions: Mitigating Class Action Litigation Risk

USA - October 12 2020 Special purpose acquisition companies (SPACs) are increasingly being used as an alternate vehicle to traditional initial public offerings. Companies…

Jay Pomerantz, Marie Bafus, Nicolas H.R. Dumont.

The $600 Billion Main Street Loan Programs: Is Your Technology or Life Sciences Company Eligible?

USA - April 13 2020 The Federal Reserve and Department of Treasury published additional details regarding two new loan programs that provide up to $600 billion for…

Alexandra Wood, Lisa Richards, Ran Ben-Tzur.

SEC’s New Guidance on Liability Risks Likens SPACs to IPOs

USA - April 9 2021 John Coates, Acting Director of the Division of Corporation Finance at the U.S. Securities and Exchange Commission (SEC), issued a public statement…

Dean Kristy, Jay Pomerantz, Ran Ben-Tzur.

Considerations in Adopting Poison Pills in the COVID-19 Environment

USA - April 13 2020 ​​ Market volatility arising from the COVID-19 pandemic may lead to increased hostile takeover activity and shareholder activism as some companies…

Douglas N. Cogen, Ethan A. Skerry.